The Cochrane database of systematic reviews

Preventing self-harm and suicide in young people up to age 25 in schools and colleges

Updated

Abstract

Fifty-one trials with 36,414 participants were included in the review of interventions for self-harm and suicide prevention in educational settings.

  • Evidence on the effectiveness of universal interventions for self-harm is of very low certainty, showing little to no difference in acceptability compared to control groups.
  • Low-certainty evidence suggests that selective interventions may slightly reduce self-harm postintervention, but evidence on their effect on suicidal ideation and hopelessness is limited.
  • Indicated interventions show low-certainty evidence indicating a potential slight reduction in self-harm and suicidal ideation, with no significant impact on hopelessness.
  • The review highlights a lack of data on the impact of interventions on key outcomes such as coping skills and safety in the environment for young people.

Simplified

Funding

Competing interests

Vartika Sharma: none known. David Marshall: no relevant interests; Editor of Cochrane Common Mental Disorders (closed in March 2023) but was not involved in the editorial process of the review. Anna Boggis: none known. Emily MacLeod: none known. Claire Mitchell: University of Auckland (employment); Clinical psychologist, Te Whatu Ora. Alison Clarke: no relevant interests; trainee clinical psychologist at Health Service Executive, Ireland. Annabelle Prescott: no relevant interests; a youth alcohol and drug practitioner, Odyssey. Jo Robinson: no relevant interests; involved in Hetrick 2017 (funded by beyondblue , an Australian organisation that aims to improve mental health literacy and decrease stigma, that also provides research funding, in the area of depression, anxiety and suicide prevention), Byrne 2022 (funded by the National Health and Medical Research Council, Australia) and Nunez 2022 (funded by the National Agency for Research and Development). Katrina Witt: International Association for Suicide Prevention (travel); Mental Health Academy (honoraria); National Health and Medical Research Council (grant). Keith Hawton: no relevant interests; a health professional at Oxford Health NHS Foundation Trust, Oxford. Sarah Hetrick: Ministry of Health New Zealand (employment); Martha Claire Loncarevic Lectureship, The Hospital for Sick Children (SickKids) (lectureship); Health Research Council New Zealand, EMBER Korowai Takatini, Oakley Mental Health Research Foundation, Cure Kids, Auckland Medical Research (grant); Douglas Goodfellow Repatriation Fellowship, Auckland Medical Research Foundation (fellowship); published papers in journals, social media, podcasts, media interviews; worked as a clinical psychologist at Headspace, Integrated youth mental health service Melbourne Victoria 2016‐2017; Co‐ordinating Editor of Cochrane Common Mental Disorders (closed in March 2023) but was not involved in the editorial process of the review; involved in Hetrick 2017 (funded by beyondblue , an Australian organisation that aims to improve mental health literacy and decrease stigma, that also provides research funding, in the area of depression, anxiety and suicide prevention). JP and SH were not involved in data extraction from Hetrick 2017.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free